- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 20.33M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 20.24M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 20.17M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.39M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.65M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.28M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.23M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $31.32M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $32.64M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $142.09M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $130.46M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $449.63M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $447.39M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $249.06M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $239.62M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $497.21M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $495.36M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $13.88M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $13.66M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$867K |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.14M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.56M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $3.85M |
| Revenue | Q1 2026 · Mar 31, 2026 | $103.13M |
| Revenue | Q1 2026 · Mar 31, 2025 | $99.23M |